KWM
ABBV icon

Kaydan Wealth Management’s AbbVie ABBV Stock Holding History

Kaydan Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Sell
1,177
-85
-7% -$18.3K 0.09% 99
2026
Q1 		$274K Buy
1,262
+94
+8% +$20.9K 0.09% 92
2025
Q4 		$267K Buy
1,168
+4
+0.3% +$911 0.08% 94
2025
Q3 		$270K Buy
1,164
+5
+0.4% +$1.02K 0.08% 96
2025
Q2 		$215K Buy
1,159
+4
+0.3% +$743 0.07% 105
2025
Q1 		$242K Buy
1,155
+5
+0.4% +$972 0.08% 96
2024
Q4 		$204K Buy
1,150
+4
+0.3% +$735 0.07% 104
2024
Q3 		$226K Buy
+1,146
New +$214K 0.07% 102
2024
Q2 		– Sell
-1,138
Closed -$207K – 104
2024
Q1 		$207K Buy
+1,138
New +$196K 0.07% 103

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Kaydan Wealth Management's ABBV Position: Q2 2026 in Review

Kaydan Wealth Management reduced its AbbVie (ABBV) stake by 6.7% in Q2 2026, selling an estimated $18.3K and leaving 1,177 shares worth $296K. The position accounts for 0.09% of the portfolio, ranked #99.

Kaydan Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kaydan Wealth Management held 1,177 shares of AbbVie worth $296K as of Q2 2026.
  • Kaydan Wealth Management sold 85 AbbVie shares in Q2 2026, an estimated $18.3K.
  • AbbVie made up 0.09% of Kaydan Wealth Management's portfolio in Q2 2026, its #99 holding.
  • Kaydan Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kaydan Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.